Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 43 páginas
Examen

APLEX ACTUAL EXAM ALL QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% VERIFIED SOLUTIONS | UPDATED PER LATEST GUIDELINES | GRADED A

Document preview thumbnail
Vista previa 4 fuera de 43 páginas

APLEX ACTUAL EXAM ALL QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% VERIFIED SOLUTIONS | UPDATED PER LATEST GUIDELINES | GRADED A

Vista previa del contenido

APLEX ACTUAL EXAM ALL QUESTIONS AND
ANSWERS ALREADY GRADED A+. 100%
VERIFIED SOLUTIONS | UPDATED PER LATEST
GUIDELINES | GRADED A

SECTION 1: PHARMACOLOGY & FOUNDATIONAL KNOWLEDGE (Questions 1-20)



Question 1
A 68-year-old female in the ICU following vascular surgery was given 14,000 units of IV
unfractionated heparin approximately 60 minutes ago. She shows signs of bleeding at the
surgical site with an elevated aPTT >120 seconds. Which agent is most appropriate to reverse
the anticoagulant effects of unfractionated heparin?

A) Andexanet alfa
B) Protamine sulfate
C) Vitamin K
D) 4-factor prothrombin complex concentrate
E) Idarucizumab

Answer: B) Protamine sulfate

Rationale: Protamine sulfate is the preferred agent for UFH reversal. It neutralizes heparin
activity by forming a stable salt. For IV heparin, 1mg of protamine per 100 units of heparin
received in the last 2-3 hours is typically administered, with a maximum single dose of 50mg.
Andexanet alfa is used for DOAC reversal (apixaban, rivaroxaban). Vitamin K and 4-PCC are for
warfarin reversal. Idarucizumab is for dabigatran reversal .



Question 2
Which of the following vaccines is contraindicated in immunocompromised patients?

A) Pneumococcal polysaccharide vaccine (PPSV23)
B) Varicella vaccine

,C) Meningococcal conjugate vaccine
D) Subcutaneous influenza vaccine

Answer: B) Varicella vaccine

Rationale: Live-attenuated vaccines (MMR, varicella, live attenuated influenza [LAIV], rotavirus)
are contraindicated in severely immunocompromised patients due to the risk of vaccine-
associated disease. Inactivated vaccines (pneumococcal, meningococcal, inactivated influenza)
are safe and recommended .



Question 3
The efficacy of beta-lactam antimicrobials is best predicted by which
pharmacokinetic/pharmacodynamic parameter?

A) Peak serum concentration (Cmax)
B) Time above the minimum inhibitory concentration (T > MIC)
C) Area under the curve to MIC ratio (AUC/MIC)
D) Trough serum concentration

Answer: B) Time above the minimum inhibitory concentration (T > MIC)

Rationale: Beta-lactams (penicillins, cephalosporins, carbapenems) exhibit time-dependent
killing. Efficacy correlates with the percentage of the dosing interval during which free drug
concentrations exceed the MIC. This is why beta-lactams are often administered by prolonged
infusion or multiple daily doses .



Question 4
Which pharmacokinetic parameter would be most affected by a drug that is a substrate for
CYP3A4 when co-administered with a strong CYP3A4 inducer?

A) Bioavailability
B) Volume of distribution
C) Clearance
D) Protein binding

Answer: C) Clearance

Rationale: CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine) increase the metabolism
of CYP3A4 substrates, leading to increased clearance and reduced drug concentrations. This may
result in therapeutic failure. Strong inducers can reduce AUC of sensitive substrates by >80% .

,Question 5
A patient is receiving vancomycin for methicillin-resistant Staphylococcus aureus (MRSA)
bacteremia. Which laboratory parameter should be monitored to assess for vancomycin-
induced nephrotoxicity?

A) Serum creatinine and BUN
B) Serum potassium
C) Serum sodium
D) Serum magnesium

Answer: A) Serum creatinine and BUN

Rationale: Vancomycin can cause acute kidney injury, particularly when trough levels exceed 15-
20 mcg/mL or when co-administered with other nephrotoxins (e.g., aminoglycosides, contrast
dye). Serum creatinine and BUN should be monitored at least weekly (or more frequently in
unstable patients).



Question 6
A 55-year-old patient with atrial fibrillation is started on warfarin. Which laboratory test is used
to monitor warfarin therapy?

A) aPTT
B) INR (International Normalized Ratio)
C) Anti-factor Xa
D) Platelet count

Answer: B) INR (International Normalized Ratio)

Rationale: Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X). The INR is the
standardized measure of prothrombin time used to monitor warfarin therapy. Target INR is
typically 2-3 for most indications (e.g., atrial fibrillation, DVT) and 2.5-3.5 for mechanical heart
valves. aPTT monitors heparin. Anti-factor Xa monitors LMWH and fondaparinux .



Question 7
Which of the following is the rate-limiting enzyme in cholesterol synthesis?

A) Acetyl-CoA carboxylase
B) HMG-CoA reductase

, C) Lipoprotein lipase
D) Acyl-CoA cholesterol acyltransferase

Answer: B) HMG-CoA reductase

Rationale: HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate, the rate-
limiting step in cholesterol synthesis. Statins (atorvastatin, rosuvastatin, simvastatin)
competitively inhibit HMG-CoA reductase, reducing hepatic cholesterol production and lowering
LDL-C.



Question 8
A patient is started on metformin for type 2 diabetes mellitus. What is the primary mechanism
of action of metformin?

A) Increases insulin secretion from pancreatic beta cells
B) Decreases hepatic glucose production and increases peripheral insulin sensitivity
C) Delays carbohydrate absorption in the gastrointestinal tract
D) Increases glucose excretion in the urine

Answer: B) Decreases hepatic glucose production and increases peripheral insulin sensitivity

Rationale: Metformin is a biguanide that reduces hepatic glucose production (gluconeogenesis)
and enhances peripheral glucose uptake and utilization. It does not increase insulin secretion
(unlike sulfonylureas and GLP-1 agonists) and rarely causes hypoglycemia. SGLT2 inhibitors
increase urinary glucose excretion.



Question 9
What is the recommended maximum daily dose of acetaminophen for a healthy adult?

A) 2,000 mg
B) 3,000 mg
C) 4,000 mg
D) 6,000 mg

Answer: C) 4,000 mg

Rationale: The maximum recommended daily dose of acetaminophen is 4,000 mg/day (or 3,000
mg/day in patients with hepatic impairment or chronic alcohol use). Hepatotoxicity occurs at
doses >7.5-10g. N-acetylcysteine is the antidote for acetaminophen toxicity.

Información del documento

Subido en
18 de agosto de 2026
Número de páginas
43
Escrito en
2026/2027
Tipo
Examen
Contiene
Desconocido
$25.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
BestwriterGuru
4.8
(721)
Vendido
221
Seguidores
32
Artículos
5017
Última venta
3 horas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes